Overview
- Adjusted EPS for Q4 was $1.67 and net sales were $7.64 billion, both ahead of forecasts despite a 1.7% sales decline tied to planned store closures.
- Comparable sales rose 1.8% in Q4 and Macy’s returned to full‑year comparable‑sales growth in 2025 as reimagined locations and premium banners outperformed.
- Bloomingdale’s posted 8.5% sales growth with 9.9% comparable gains, while Bluemercury increased sales about 2.5%, outpacing the Macy’s nameplate.
- For 2026, Macy’s guided net sales to $21.4–$21.65 billion and adjusted EPS to $1.90–$2.10, citing a prudent stance given consumer and geopolitical uncertainty.
- Tariffs are expected to hit margins most in Q1 before easing in the second half, following a move to a uniform 10% duty that has created near‑term inventory cost mismatches; shares rose roughly 8%–9% premarket after the report.